Accuray Incorporated · NASDAQ (us_market)
Healthcare · Medical Devices · United States
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-08$0.89 RISE2026-05-15$0.27 PEAK2026-05-28$0.42 140d | -69.7% 127d | Missed | Missed | — | — | +55.6% 13d | Missed |
DROP2025-12-11$1.10 RISE2026-03-30$0.34 PEAK2026-05-06$0.48 146d | -69.1% 109d | Missed | Missed | — | — | +41.2% 37d | Missed |
DROP2025-03-25$1.90 RISE2025-08-01$1.28 PEAK2025-10-09$1.85 198d | -32.6% 129d | Missed | Missed | — | — | +44.5% 69d | Missed |
DROP2025-02-10$2.45 RISE2025-06-20$1.22 PEAK2025-08-18$1.62 189d | -50.2% 130d | Missed | Missed | — | — | +32.8% 59d | Missed |
DROP2025-02-06$2.69 RISE2025-06-13$1.22 PEAK2025-08-18$1.62 193d | -54.6% 127d | Missed | Missed | — | — | +32.8% 66d | Missed |
DROP2025-02-06$2.69 RISE2025-05-06$1.30 PEAK2025-05-20$1.74 103d | -51.7% 89d | Missed | Missed | — | — | +33.8% 14d | Missed |
DROP2024-08-21$2.49 RISE2024-12-30$1.79 PEAK2025-02-06$2.69 169d | -28.1% 131d | Missed | Missed | — | — | +50.3% 38d | Missed |
DROP2024-08-21$2.49 RISE2024-12-19$1.79 PEAK2025-02-06$2.69 169d | -28.1% 120d | Missed | Missed | — | — | +50.3% 49d | Missed |
DROP2024-08-21$2.49 RISE2024-12-18$1.79 PEAK2025-02-06$2.69 169d | -28.1% 119d | Missed | Missed | — | — | +50.3% 50d | Missed |
DROP2024-08-21$2.49 RISE2024-11-18$1.70 PEAK2025-02-06$2.69 169d | -31.7% 89d | Missed | Missed | — | — | +58.2% 80d | Missed |
DROP2024-08-21$2.49 RISE2024-11-15$1.70 PEAK2025-02-06$2.69 169d | -31.7% 86d | Missed | Missed | — | — | +58.2% 83d | Missed |
DROP2024-08-21$2.49 RISE2024-09-25$1.70 PEAK2024-11-29$2.23 100d | -31.7% 35d | Missed | Missed | — | — | +31.2% 65d | Missed |
DROP2024-04-09$2.41 RISE2024-08-12$1.41 PEAK2024-08-21$2.49 134d | -41.5% 125d | Missed | Missed | — | — | +76.6% 9d | Missed |
DROP2024-01-22$2.94 RISE2024-05-23$1.49 PEAK2024-08-19$2.35 210d | -49.3% 122d | Missed | Missed | — | — | +57.7% 88d | Missed |
DROP2023-10-05$3.08 RISE2024-02-05$2.38 PEAK2024-03-08$2.90 155d | -22.7% 123d | Missed | Missed | — | — | +21.8% 32d | Missed |
1–15 / 28 1 / 2 | |||||||
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health announced a new 10‑year strategic collaboration to advance...
Accuray Inc (NASDAQ:ARAY) is one of the best small cap robotics stocks to buy according to analysts. The March quarter results that Accuray Inc (NASDAQ:ARAY) reported on May 6 showed the company’s revenue decreased, and the loss widened. The company revealed problems in its Middle East market, citing geopolitical uncertainties. It said the Middle East […]
Jefferies analyst Young Li downgrades Accuray (NASDAQ:ARAY) from Buy to Hold and lowers the price target from $3.5 to $0.35.
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
The recent 17% drop in Accuray Incorporated's ( NASDAQ:ARAY ) stock could come as a blow to insiders who purchased...
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Wall Street analysts changed outlook on top names, downgraded Amplitude Inc, Accuray Inc, Angi Inc, PayPal Holdings, and Criteo S.A. See analyst ratings.
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Analysts view APRE, SRFM, CNH stocks.
BTIG analyst Marie Thibault downgrades Accuray (NASDAQ:ARAY) from Buy to Neutral.
Accuray Incorporated (ARAY) Q3 2026 Earnings Call May 6, 2026 4:30 PM EDTCompany ParticipantsStephen Monroe - Vice President of Financial Planning &...
Presentation Operator MessageOperator Good day, and welcome to the Accuray Third Quarter Fiscal Year 2026 Financial Results Conference Call. [Operator Instructions] Please note this event is being...
2026-05-07. The following slide deck was published by Accuray Incorporated in conjunction with their 2026 Q3 earnings call.
Stephen Monroe: Thank you, and good afternoon, everyone. Welcome to Accuray Incorporated's conference call to review financial results for the third quarter of fiscal 2026, which ended 03/31/2026. Joining us on today's call are Stephen LaNeve, Accuray Incorporated's President and Chief Executive Officer, and Ali Pervaiz, Accuray Incorporated's Chief Financial Officer.
Accuray (NASDAQ:ARAY) reported fiscal third-quarter 2026 results marked by modest sequential revenue growth but pressure from geopolitical disruptions and ongoing headwinds in China, prompting the company to withdraw its financial guidance. Quarterly results affected by Middle East disruptions and
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ARAY | -19.15% | -30.91% | -53.66% | -75.16% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -22.12% | -25.19% | -50.22% | -87.85% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| RenTech | quant | 2.29M | $889.13K | 0.00% | Trimmed-6.6% | 2026-03-31 |
| StateStreet | passive | 2.02M | $783.05K | 0.00% | Added+1.1% | 2026-03-31 |
| FidelityFMR | fundamental | 1.29M | $500.18K | 0.00% | Added+21.2% | 2026-03-31 |
| DEShaw | quant | 843.6K | $327.42K | 0.00% | Trimmed-49.9% | 2026-03-31 |
| TwoSigma | quant | 23.4K | $9.08K | 0.00% | Trimmed-90.1% | 2026-03-31 |
| TRowePrice | fundamental | 50.8K | $20 | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.03 | — | — |
| 2026-05-06 | -0.05 | -0.07 | -35.60% |
| 2026-02-04 | -0.11 | -0.11 | +2.18% |
| 2025-11-05 | -0.05 | -0.14 | -178.40% |
| 2025-08-13 | 0.02 | 0.01 | -63.33% |
| 2025-04-30 | -0.05 | -0.01 | +81.25% |
| 2025-02-05 | -0.04 | 0.02 | +150.00% |
| 2024-11-06 | -0.06 | -0.04 | +38.46% |
| 2024-08-14 | 0.03 | 0.03 | +12.49% |
| 2024-05-01 | -0.02 | -0.06 | -259.93% |
| 2024-01-31 | -0.04 | -0.10 | -150.00% |
| 2023-11-07 | -0.05 | -0.03 | +45.45% |
| 2023-08-09 | 0.01 | -0.02 | -273.00% |
| 2023-04-26 | -0.01 | 0.01 | +171.43% |
| 2023-02-01 | -0.03 | -0.02 | +37.50% |
| 2022-11-02 | -0.03 | -0.06 | -87.50% |